No Data
No Data
Vistagen, The Goldie Hawn Foundation, and MindUP Students to Ring Nasdaq Closing Bell on World Mental Health Day
All You Need to Know About VistaGen Therapeutics (VTGN) Rating Upgrade to Buy
Companies Like Vistagen Therapeutics (NASDAQ:VTGN) Are In A Position To Invest In Growth
Maxim Group Maintains VistaGen Therapeutics(VTGN.US) With Buy Rating, Maintains Target Price $12
Buy Rating Affirmed on VistaGen Therapeutics Amid Strong Financials and Promising Clinical Trials
Earnings Call Summary | VistaGen Therapeutics(VTGN.US) Q1 2025 Earnings Conference
No Data
No Data